Al­ler­gan en­lists Ex­i­cure in search of hair loss drugs with $25M up­front, dou­bling down on area dear to Ab­b­Vie

Af­ter Ab­b­Vie be­came a for­mi­da­ble play­er in med­ical aes­thet­ics overnight by swal­low­ing Al­ler­gan, the Botox mak­er is beef­ing up the pipeline with new R …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.